Skip to main navigation Skip to search Skip to main content

Salvage chemoimmunotherapy with inotuzumab ozogamicin combined with mini-hyper-CVD for patients with relapsed or refractory philadelphia chromosome-negative acute lymphoblastic leukemia: A phase 2 clinical trial

  • Elias Jabbour
  • , Farhad Ravandi
  • , Partow Kebriaei
  • , Xuelin Huang
  • , Nicholas J. Short
  • , Deborah Thomas
  • , Koji Sasaki
  • , Michael Rytting
  • , Nitin Jain
  • , Marina Konopleva
  • , Guillermo Garcia-Manero
  • , Richard Champlin
  • , David Marin
  • , Tapan Kadia
  • , Jorge Cortes
  • , Zeev Estrov
  • , Koichi Takahashi
  • , Yogin Patel
  • , Maria R. Khouri
  • , Jovitta Jacob
    • Rebecca Garris, Susan O'Brien, Hagop Kantarjian

Research output: Contribution to journal › Article › peer-review

150   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Salvage chemoimmunotherapy with inotuzumab ozogamicin combined with mini-hyper-CVD for patients with relapsed or refractory philadelphia chromosome-negative acute lymphoblastic leukemia: A phase 2 clinical trial'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Keyphrases